| # | Drug | Count |
|---|---|---|
| 0 | ROMIPLOSTIM | 117 |
| 1 | ELTROMBOPAG OLAMINE | 54 |
| 2 | PREDNISONE | 31 |
| 3 | RITUXIMAB | 21 |
| 4 | ALLOPURINOL | 18 |
| 5 | ELTROMBOPAG | 16 |
| 6 | DANAZOL | 14 |
| 7 | HYDROXYUREA | 12 |
| 8 | ANAGRELIDE | 10 |
| 9 | METHYLPREDNISOLONE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ROMIPLOSTIM | 117 | 0.0077 |
| 1 | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | 1 | 0.0068 |
| 2 | COCOA BUTTER, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0054 |
| 3 | AMINOCAPROIC ACID | 4 | 0.0050 |
| 4 | DANAZOL | 14 | 0.0049 |
| 5 | ELTROMBOPAG OLAMINE | 54 | 0.0023 |
| 6 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 1 | 0.0010 |
| 7 | ANAGRELIDE HYDROCHLORIDE | 1 | 0.0009 |
| 8 | PROCHLORPERAZINE EDISYLATE | 1 | 0.0008 |
| 9 | PENTAMIDINE ISETHIONATE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Thrombopoietin Receptor Agonist [EPC] | 117 |
| 1 | Corticosteroid [EPC] | 38 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 21 |
| 3 | Xanthine Oxidase Inhibitor [EPC] | 18 |
| 4 | Androgen [EPC] | 14 |
| 5 | beta-Adrenergic Blocker [EPC] | 13 |
| 6 | Antimetabolite [EPC] | 12 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| 9 | Kinase Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thrombopoietin Receptor Agonist [EPC] | 117 | 0.0077 |
| 1 | Antifibrinolytic Agent [EPC] | 6 | 0.0006 |
| 2 | Androgen [EPC] | 14 | 0.0005 |
| 3 | Human Immunoglobulin G [EPC] | 7 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 5 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 6 | Iron Chelator [EPC] | 6 | 0.0002 |
| 7 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 8 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Vitamin D Analog [EPC] | 2 | 0.0001 |